期刊文献+

Ki-67和P53的表达与原发性上尿路尿路上皮癌术后发生膀胱癌的关系 被引量:1

Relationship between expression of Ki-67 and P53 and intravesical recurrence in patients with primary upper tract urothelial carcinomas after radical nephroureterectomy
原文传递
导出
摘要 目的 研究肿瘤标记物Ki-67和P53在上尿路尿路上皮癌中的表达情况,结合传统临床病理参数分析原发性上尿路肿瘤根治术后发生膀胱癌的危险因素.方法 回顾性分析1 15例原发性上尿路肿瘤根治术后的临床病理资料.免疫组织化学检测肿瘤标记物Ki-67和P53蛋白在尿路上皮癌中的表达情况,联合传统临床病理参数多因素分析上尿路肿瘤术后发生膀胱癌的危险因素.结果 Ki-67在肿瘤标本中正常表达率44.87% (48/107),过表达率55.13%(59/107).P53在肿瘤标本表达阴性率34.86% (38/109),弱阳性率25.69% (28/109),阳性率17.43%(19/109),强阳性率22.02% (24/109).Ki-67和P53表达均与肿瘤分级有关(P =0.003).原发性上尿路尿路上皮癌术后膀胱癌的发生率为11.30%(13/115),平均随访时间为48.50个月(7~130个月).多因素生存分析发现患病年龄>65岁(P=0.040),输尿管下段肿瘤(P =0.008)和Ki-67低表达(P=0.041)可作为膀胱癌出现的预测因素.结论 Ki-67正常表达可作为原发性上尿路尿路上皮癌术后发生膀胱癌的独立危险因素. Objectives To investigate expression of biomarkers Ki-67 and P53 in primary upper tract urothelial carcinoma tissues.Combined with conventional cliniopathological parameters,their correlation with bladder tumor recurrence was analysised in patients with primary upper tract urothelial carcinomas after radical nephroureterectomy.Methods The data of 115 patients with primary upper tract urothelial carcinomas was collected and analyzed retrospectively.The expression of tumor markers Ki-67 and P53 protein were detected by immunohistochemistry.Combined with traditional cliniopathological factors and biomarkers,risk factors of bladder tumor recurrence were explored.Results Normal expression rate of Ki-67 was 44.87% (48/107),and over-expression rate was 55.13% (59/107).negative expression rate of P53 was 34.86% (38/109),mild positive rate was 25.69% (28/109),positive rate was 17.43% (19/109),and strong positive rate was 22.02% (24/109).Expressions of Ki-67 and P53 were both associated with tumor grade(P =0.003).The incidence of bladder cancer was 11.30% (13/115) in patients with the primary upper tract urothelial carcinomas after radical nephroureterectomy,and the mean follow-up time was 48.50 months (7 ~ 130 months).Prevalence age was more than 65 years by multivariate survival analysis(P =0.040),ureteral tumors (P =0.008) and the low expression of Ki-67 (P =0.041) were independent predictors for bladder cancer.Conclusions Normal expression of Ki-67 can be an independent predictor for bladder tumor recurrence in primary upper tract urothelial carcinomas after radical nephroureterectomy.
出处 《国际泌尿系统杂志》 2016年第5期676-680,共5页 International Journal of Urology and Nephrology
关键词 膀胱肿瘤 泌尿系肿瘤 KI-67抗原 肿瘤抑制蛋白质P53 Urinary Bladder Neoplasms Urologic Neoplasms Ki - 67 Antigen Tumor Suppressor Protein p53
  • 相关文献

参考文献16

  • 1Gakis G, Witjes JA, Comperat E, et al. EAU guidelines on primary urethral carcinoma [ J ]. Eur Urol, 2013,64 (5) : 823 - 830.
  • 2Shariat SF, Karakiewicz PI, Ashfaq R, et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy [ J ]. Cancer, 2008,112 ( 2 ) : 315 - 325.
  • 3Krabbe LM, Bagrodia A, Lotan Y, et al. Prospective analysis of Ki - 67 as an independent predictor of oncologic outcomes in patientswith high grade upper tract urothelial carcinoma [ J ]. J Urol,2014, 191(1) :28 -34.
  • 4周利群,李学松,熊耕砚.中国人群上尿路尿路上皮癌新进展[J].北京大学学报(医学版),2014,46(4):504-506. 被引量:44
  • 5樊国栋,李培军.69例肾盂和输尿管癌术后发生膀胱肿瘤的相关因素分析[J].宁夏医科大学学报,2012,34(7):716-718. 被引量:4
  • 6杨建军,王晓明,姚茂银.上尿路移行细胞癌术后继发膀胱癌的临床观察[J].中华泌尿外科杂志,2005,26(3):204-204. 被引量:1
  • 7Ding W,Gou Y, Sun C, et al. Ki - 67 is an independent indicator in non - muscle invasive bladder cancer ( NM1BC ) ; combination of EORTC risk scores and Ki -67 expression could improve the risk stratification of NMIBC [ J ]. Urol Oncol,2014,32 (1) :13 - 42.
  • 8Green DA, Rink M, Xylinas E, et al. Urothelial carcinoma of the bladder and the upper tract: disparate twins [ J ]. J Urol,2013,189 (4) :1214 - 1221.
  • 9Feng C, Wang L, Ding G, et al. Predictive value of clinicopathologi- cal markers for the metachronous bladder cancer and prognosis of upper tract urothelial carcinoma [ J ]. Sci Rep, 2014,4 ( 2 ) : 4015,.
  • 10Zigeuner RE, Hutterer G, Chromecki T,et al. Bladder tumour de- velopment after urothelia3 carcinoma of the upper urinary tract is related to primary tumour location [ J ]. BJU Int, 2006,98 (6) : 1181 -1186.

二级参考文献40

  • 1李卫华,杨莉,苏涛,宋毅,李晓玫.服用含马兜铃酸成分药物对尿毒症透析患者伴发尿路移行细胞癌的影响[J].中华医学杂志,2005,85(35):2487-2491. 被引量:29
  • 2孔垂泽,刘奔,李振华,杨绍波,孙志熙.预防肾盂输尿管癌术后再发膀胱癌的手术方法研究[J].中华泌尿外科杂志,2006,27(4):250-252. 被引量:22
  • 3吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.589-591.
  • 4Hisataki T,Miyao N,Masumori N,et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology,2000,55:663 -567.
  • 5Hisataki T, Miyao N, Masumori N, et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer[ J]. Urology,2000,55:663 - 667.
  • 6Matsui Y, Utsunomiya N, Ichioka K, et al. Risk factors for subsequent development of bladder cancer after pri- mary transitional cell carcinoma of the upper urinary tract[ J]. Urology,2005,65:279 - 283.
  • 7Tsunenori K, Shiro O, Osamu R, et al. Analysis of prog- nostic factors related to primary superficial bladder eanc-er tumor recurrence in prophylactic intravesical epirubi- cin therapy[ J]. Internation Journal of Urology, 1999,6 : 178 - 183.
  • 8Hall MC, Womaek S, Sagaloeskyv AI, et al. Prognostic factors, recurrence, and survival in transitional cell car- cinoma of the upper urinary tract : a 30 - year experience in 252 patients [ J ]. Urology, 1998,52 : 594 - 601.
  • 9Simon V. Bariol, Grant D. Stewart, et al. Oncological con- trol following laparoscopic nephroureterectomy : 7 - year outcome [ J ]. The Journal of Uro|ogy, 2004, 172: 1805 - 1808.
  • 10Sakamoto N, Naito S, Kumazawa J,et al. Prophylactic in- travesical instillation of mitomycin C and cytosine arabi- noside for preventior of recurrent bladder tumors follow- ing surgery for upper urinary tract tumors:a prospective randomized study [ J ]. International Journal of Urology, 2001,8:212 -216.

共引文献46

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部